insights_auto
Why is AGIO down 4,03%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
27,60 USD
arrow_downward
-4,03%(-1,16) 1D
27,60 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 20-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
28,01 USD
High
29,14 USD
Low
27,43 USD
Mkt. cap
1,65 млд
Avg. vol.
1,13 млн
Volume
776,20 миң
52-wk high
44,07 USD
52-wk low
23,02 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
28,01 USD
High
29,14 USD
Low
27,43 USD
Mkt. cap
1,65 млд
Avg. vol.
1,13 млн
Volume
776,20 миң
52-wk high
44,07 USD
52-wk low
23,02 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
AP News
·
1 күн мурун
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
The Motley Fool
·
11 саат мурун
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
24/7 Wall St.
·
1 саат мурун
Billionaire Ray Dalio's Bridgewater Keeps 16% of Its $23 Billion Stock Portfolio in S&P 500 Index Funds, Even After Cutting Them
Beinsure
·
1 күн мурун
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc